Innovation Economics (Pt. 1): “Pull” Mechanisms, Mostly Prizes Stephen M. Maurer Designing Strategies for Neglected Disease Research Law 284.26 Public.

Slides:



Advertisements
Similar presentations
Thinking About Bioshield Stephen M. Maurer Information & Homeland Security Project UC Berkeley/Goldman School of Public Policy IGCC/AAAS.
Advertisements

COST-BENEFIT ANALYSIS AND INCENTIVES IN EVALUATION: PUBLIC- PRIVATE PARTNERSHIPS Open Days 2006 Brussels 9-12 October 2006 Professor Massimo Florio University.
Producer decision Making Frederick University 2013.
Chapter 20 Cost 20-1 Copyright 2002 by The McGraw-Hill Companies, Inc. All rights reserved.
Prof Parameshwar P Iyer Indian Institute of Science1 Entrepreneurship and Business Management Mega Bucks Workshop Indian Institute of Technology Kanpur.
Lecture 4A: The Bioshield Dilemma: Developing New Technologies At an Affordable Price Introduction to Homeland Security Sept. 21, 2005 Stephen M. Maurer.
The Strategy of International Business
Managerial Economics & Business Strategy Chapter 1 The Fundamentals of Managerial Economics McGraw-Hill/Irwin Michael R. Baye, Managerial Economics and.
Presented By:- Dharm Jeeta Singh
Macroeconomics Unit 12 Deficits, Surpluses, Debt Top Five Concepts.
Finding Cures for Tropical Diseases: Putting Innovation Economics to Work Stephen M. Maurer Goldman School of Public Policy Nov. 21, 2006 Economics of.
Incentives and the Innovative Environment Suzanne Scotchmer ESNIE, Cargèse, May 2007 references: Chs 2, 8 Innovation and Incentives (MIT Press, 2005)
Copyright © 2008 McGraw-Hill Ryerson Ltd.1 Chapter Eight Corporate Social Responsibility: In Practice.
The Fundamentals of Managerial Economics Pertemuan 1-2 Matakuliah: J0434/EKONOMI MANAJERIAL Tahun: 2008.
1 Chapter 1: Goal and Functions of Finance Objective of the Firm – the primary goal of the firm is to maximize stockholder wealth Wealth Maximization versus.
© Suzanne Scotchmer 2007 Contents May Be Used Pursuant to Creative Commons Attribution-NoDerivs-NonCommercial Common Deed 1.0Attribution-NoDerivs-NonCommercial.
Beyond the Ivory Tower: Making Practical Choices Stephen M. Maurer Goldman School of Public Policy & Berkeley Law School March 16, 2009.
Where to Find the Course: Home Page: Wiki:
Finding Cures for Tropical Diseases: Choosing the Right Incentives Stephen M. Maurer Goldman School of Public Policy, UC Berkeley May 23, 2007 European.
1 An Introduction to IP Law and Economics Stephen M. Maurer Goldman School of Public Policy IT and Public Policy – Sept. 30, 2004.
Managerial Economics & Business Strategy
Managerial Economics & Business Strategy Chapter 1 The Fundamentals of Managerial Economics McGraw-Hill/Irwin Michael R. Baye, Managerial Economics and.
State and Local Public Finance Spring 2015, Professor Yinger Lecture 5 Public Sector Costs: Policy.
Copyright © 2008 by The McGraw-Hill Companies, Inc. All rights reserved. McGraw-Hill/Irwin 20 Strategy, Balanced Scorecards and Incentive Systems.
2 The Domestic and International Financial Marketplace ©2006 Thomson/South-Western.
Pension Plan By: Jennifer Kimball. What is a Pension?! A Pension is a plan that sends you money after you are retired or aren't working anymore. Pensions.
Innovation Economics (Pt. 2): “Push” Mechanisms, Mostly Private-Public Partnerships Private-Public Partnerships Stephen M. Maurer Designing Strategies.
The Strategy of International Business
Business Education in Russia: Challenges and Trends Vladimir MAU July 15, 2008.
McGraw-Hill/Irwin © 2004 The McGraw-Hill Companies, Inc., All Rights Reserved. Monopoly Chapter 12.
Advances in Human Resource Development and Management Course code: MGT 712 Lecture 14.
© 2007 Thomson South-Western. In this section, look for the answers to these questions: Why does productivity matter for living standards? What determines.
Bellwork Write Five sentences about how you feel about your performance in the class so far.
Economics for Leaders Lesson 8: Costs & Benefits Of Government Action.
Characteristics of firms engaged in collaborations Charlene Lonmo Science, Innovation and Electronic Information Division Statistics Canada Presentation.
Public Partnerships with the Private Sector AIP-RURAL.
Incentives for Innovation (Push and Pull) Andrew Alexandra Director Australian Research Council Special Research Centre for Applied Philosophy and Public.
Chapter 21: The Costs of Production McGraw-Hill/Irwin Copyright © 2013 by The McGraw-Hill Companies, Inc. All rights reserved. 13e.
Developing A Price Structure
Marketing & Strategic Management A Framework for Agribusiness Strategy AEC 422 Fall 2014 Lecture 1.
Unit 4, Lesson 10 Competition AOF Business Economics Copyright © 2008–2011 National Academy Foundation. All rights reserved.
1 Chapter 12 Budget Balance and Government Debt. 2 Budget Terms A Budget Surplus exists when Tax Revenues are greater than expenditures and is the difference.
Organizational Design, Responsibility Accounting and Evaluation of Divisional Performance Chapter 18.
©2004 by South-Western/Thomson Learning 1 The External Environment: Opportunities, Threats, Industry Competition, and Competitor Analysis Robert E. Hoskisson.
© Suzanne Scotchmer Contents May Be Used Pursuant to Creative Commons Attribution-NoDerivs-NonCommercial Common Deed 1.0 Attribution-NoDerivs-NonCommercial.
1 Chapter 12 Budget Balance and Government Debt. 2 Budget Terms A Budget Surplus exists when Tax Revenues are greater than expenditures and is the difference.
MCS UNS chapter 6 :Variance Analysis
Developing A Price Structure Chapter 16. Price Administration Price administration is also concerned with handling price adjustments for sales made under.
Public Private Partnerships An Academic Understanding, or Not 2003 NEFPP Annual Conference.
DWU #1 – 2/5 “Economics is the study of how individuals use money to consume, create, and distribute goods. “ -Explain how the choices we make in our daily.
Strong Medicine: Designing Pharmaceutical Markets to Treat Neglected Diseases Michael Kremer May 9, 2008 Harvard University, Brookings Institution, Center.
Patents, Prizes, AMCs and CAMCs Aidan Hollis University of Calgary October 2007.
What is this course about?
Company Name Description of Plan Todays Date. 24/01/2016 Objectives Your target = £X per annum. Average order value £X– then you need to work out how.
The Pilot Advance Market Commitment for Vaccines Tania Cernuschi Senior Manager, AMC GAVI Alliance Marketplace on Innovative.
21-1 The Costs of Production  Before anyone can consume to satisfy wants and needs, goods and services must be produced.  Producers are profit-seeking,
BUSINESS MANAGEMENT – HIGHER BUSINESS ENTERPRISE Business in Contemporary Society Business Objectives.
Sofia Arsenal Museum of Contemporary Art February 7, 2012 J. Gabriel Goddard Senior Economist World Bank.
Copyright ©2003 South-Western/Thomson Learning Chapter 2 The Domestic and International Financial Marketplace.
Chapter 2 The Domestic and International Finance Marketplace © 2001 South-Western College Publishing.
Current situation: bad pharma or bad patents? Inefficiencies through the patent protection process Return to patent protection rewards pharma profits –
Chapter 2 and 3 Economics Chapter 2 and 3 Economics.
Competition and Intellectual Property Protection in the Pharmaceutical Sector Alexey Ivanov Director, HSE-Skolkovo Institute for Law and Development Director,
Intellectual Property - Patents, Copyrights, and Other Protectionist Barriers CEPR Basic Economics Seminar Dean Baker November 17, 2005.
Deficits, Surpluses, and the National Debt
Venture Capital Guiding Fund for Technology-based SMEs
Entrepreneurship and Business Management
Inventing Institutions
Econ 101: Intermediate Macroeconomic Theory Larry Hu
What affects our business from the outside?
Presentation transcript:

Innovation Economics (Pt. 1): “Pull” Mechanisms, Mostly Prizes Stephen M. Maurer Designing Strategies for Neglected Disease Research Law Public Policy 190/290

“Never Believe an Experiment Until It’s Confirmed in Theory.” A.S. Eddington A First Principles Approach A Different Way to Think About Innovation Binning and Comparing Ad hoc arguments Push & Pull Next Three Lectures: Big Picture Later: Nuts-and-Bolts Introduction

Review: Social Challenges Ex Ante Efficiency (v - c) Ex Post Efficiency “Access” Eliciting Privately Held Information Agency Problems (Sponsors) Agency Problems (Researchers) (Political Feasibility) Review

Toolbox Boosted Demand Prizes Advanced Purchase Commitments Grants Private Public Partnerships Contract R&D Open Source Review

Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) ???? Eliciting Privately Held Knowledge Ex Post Efficiency “Access” Another Cartoon ?? (Politics:) All innovation mechanisms have strengths and weaknesses. What are the main social challenges?

A Warm-Up Exercise Boosted Demand

Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) ???? Eliciting Privately Held Knowledge Ex Post Efficiency “Access” Boosted Demand ?? (Politics:) Ex Ante Efficiency (v - c) The “sunk costs” problem Fixes Signaling with current budgets. Make the promise enforceable?

Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) ??? Eliciting Privately Held Knowledge: Ex Post Efficiency “Access” Boosted Demand √ ? (Politics:) ? Eliciting Private Knowledge Basic Idea: Asking the World Details: Knowledge Distributed Between Firms, Knowledge as Experience Good.

Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) ?? Eliciting Privately Held Knowledge Ex Post Efficiency “Access” Boosted Demand √ ? √ (Politics:) ? Agency Problems (Sponsors) See Above!

Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) ? Eliciting Privately Held Knowledge Ex Post Efficiency “Access” Boosted Demand √ ? √ ? (Politics:) Agency Problems (Researchers) Why We Like “Pull” Incentives √

Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) Eliciting Privately Held Knowledge Ex Post Efficiency “Access” Boosted Demand √√ √ ? Ex Post Efficiency (“Access”) Patented drugs. ? (Politics:) √

Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) Eliciting Privately Held Knowledge Ex Post Efficiency “Access” Boosted Demand √√ √ √ (Politics:) Politics Payment is Deferred (Less Visible) No formal commitment needed Blame the private sector! Politics is costly! √ ?

Today’s Main Event Prizes

Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) ???? Eliciting Privately Held Knowledge Ex Post Efficiency “Access” Prizes ?? (Politics:) Ex Ante Efficiency 1. What Kind of Effort? Blue Sky Prizes (DALYs Saved, Market tests…) Directed prizes

Prizes Ex Ante Efficiency 2. How Much Effort? … for one company? Minimum R&D Cost … for two companies? + ε “Competing Away the Profits” Congress and Patents The $800 million pill. Prejudices: Occam’s Razor, Looking Under the Lamppost, and Conspiracy Theories.

Prizes Ex Ante Efficiency 2. How Much Effort? Ctd… Pitfalls: Can set (v - c) < 0 Not the patent system ! Setting c too high: Racing, duplication, diminishing returns, and Rent-seeking. Low cost providers.

Prizes Ex Ante Efficiency 2. How much effort? Ctd… Picking a Dollar Reward The Accounting Answer Rich Nations R&D Intensity A Bare Bones Program? Would a Smaller Prize Work? Internal Financing A Very Alarming Result…

Prizes Ex Ante Efficiency 3. Second Generation & Me-Too Drugs Is v lower? c lower? Should the first generation winner share the reward? Prizes based on sales are not the Patent System Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) ???? Eliciting Privately Held Knowledge Ex Post Efficiency “Access” ? (Politics:) √

Eliciting Privately Held Knowledge 1. What Kinds of Knowledge? Example: DALYs vs. Drug Specs Prizes Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) Eliciting Privately Held Knowledge: Ex Post Efficiency “Access” (Politics:) ??? √ ??

Eliciting Private Knowledge What Kinds of Knowledge? Social vs. Science Knowledge Public Health Knowledge Pharma has… Drug expertise/proprietary data. Marketing & Psyching Out FDA But not… Psyching Out the UN Prizes

Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) ?? Eliciting Privately Held Knowledge Ex Post Efficiency “Access” √ ? √ (Politics:) ? Agency Problems (Sponsors) Sponsors Pay a Premium for Mistrust! Prizes

Agency Problems (Sponsors), ctd. … Common Examples of Prizes: Discretionary Awards DALYs Tournament Specification/First-past-the-post. Tradeoffs Enforceability vs. changing costs/needs. Enforceability vs. maximum value. Economies of scale Large budgets and repeat games. Prizes

Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) ? Eliciting Privately Held Knowledge Ex Post Efficiency “Access” √√ ? (Politics:) Agency Problems (Researchers) Why We Like “Pull” Incentives Access to Financing Special Problem: Tournaments Prizes √ ?

Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) Eliciting Privately Held Knowledge Ex Post Efficiency “Access” √√ ? Ex Post Efficiency (“Access”) See Above No Patent Required Patents + Prizes ??? (Politics:) Prizes √√√

Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) Eliciting Privately Held Knowledge Ex Post Efficiency “Access” √√ √ √ Politics Payment is Deferred (Less Visible) Blame the private sector! “Prizes are like the patent system” Prizes √ ? (Politics:)

Advanced Purchase Commitments APCs

Special Problems: Eliciting Privately Held Knowledge Why an IAC? Two-Stage Games Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) Eliciting Privately Held Knowledge Ex Post Efficiency “Access” √√ √ √ ? (Politics:) √

Grants

Ex Ante Efficiency No attempt to judge “c” But: No internal financing problem! Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) Eliciting Privately Held Knowledge Ex Post Efficiency “Access” √ ? (Politics:) ????

Grants Eliciting Privately Held Knowledge Agency Problems: Sponsors Ex Ante Efficiency (v-c) Eliciting Privately Held Knowledge √√ Short-term suppression, but reasonably quick disclosure. Agency Problems: Researchers Ex Post Efficiency “Access” ? (Politics:) ???

Grants Agency Problems: Sponsors Up-front or periodic payments Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) Eliciting Privately Held Knowledge Ex Post Efficiency “Access” √√ ? (Politics:) √ ??

Grants Agency Problems: Researchers Grant budget vs. Idea Quality S. Maurer & S. Scotchmer, “Procuring Knowledge,” in G. Libecap (ed.), Advances in the Study of Entrepreneurship, Innovation and Growth: Vol. 15, at p. 1 (JAI Press 2004). Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) Eliciting Privately Held Knowledge Ex Post Efficiency “Access” √√ ? (Politics:) √ ? √

Grants Ex Post Efficiency: Access See above! Agency Problems: Sponsors Agency Problems: Researchers Ex Ante Efficiency (v-c) Eliciting Privately Held Knowledge Ex Post Efficiency “Access” √√ ? (Politics:) √√√

Adding Patents Why you might want patents after all… Sponsor can’t judge value Taking advantage of rich nation revenues Politics But… Crowding out. Making claims on sponsor’s future budget